Venoocclusive Liver Disease
11 drugs2,995 FAERS reportsMedDRA PT
GET
/api/v1/reaction/venoocclusive-liver-diseaseReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Venoocclusive Liver Disease (11)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Betibeglogene Autotemcel715%
- 2Defibrotide3279.3%
- 3Inotuzumab Ozogamicin2538.8%
- 4Gemtuzumab Ozogamicin2597.2%
- 5Busulfan1,0345.7%
- 6Thiotepa3864.2%
- 7Dactinomycin753.5%
- 8Thioguanine673.2%
- 9Plerixafor332.3%
- 10Melphalan5412.2%
- 11Calaspargase Pegol132.0%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Venoocclusive Disease4 shared · 0.33
- Acute Graft Versus Host Disease4 shared · 0.27
- Graft Versus Host Disease3 shared · 0.18
- Chronic Graft Versus Host Disease2 shared · 0.15
- Acute Graft Versus Host Disease In Skin2 shared · 0.14
- Cystitis Haemorrhagic2 shared · 0.14
- Mucosal Inflammation7 shared · 0.13
- Haematotoxicity2 shared · 0.13
- Thrombotic Microangiopathy2 shared · 0.13
- Acute Myeloid Leukaemia4 shared · 0.12
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.